Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Nordic AML Group
Related studies linked through entity extraction aliases.